Axovia Therapeutics

Founded 2020 · $2.1M raised

Founded
2020
Business Model
B2B
Total Funding
$2.1M
Last Round
$1.1M GrantJan 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Axovia Therapeutics is leading the development of therapies that address the genetic forms of blindness and obesity associated with ciliopathies. Ciliopathies are a group of more than 55 rare inherited genetic diseases linked to more than 950 genes that affect cilia used for protein transport and cellular signaling. The lead program focuses on Bardet-Biedl Syndrome, using AAV gene therapy intended to modify the underlying disease including vision loss and obesity. The company was co-founded in 2020 by Prof. Philip Beales and Dr. Victor Hernandez as a University College London spin-off.

Summary

Axovia Therapeutics is a Biotech company, founded in 2020. It has raised $2.1M in total across 3 rounds, most recently a $1.1M Grant round in Jan 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2026
$1.1M

Sign up to see all 3 events

Funding: Corporate Round through Grant. Amounts, valuations, and investors where available.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Axovia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/axovia-therapeutics"><img src="https://indexed.vc/api/badge/company/axovia-therapeutics" alt="Axovia Therapeutics on Indexed.vc" width="260" height="76" /></a>